Bert van den Bergh
Revalesio Corporation hired Bert van den Bergh as president to accelerate commercialization of its therapeutic, RNS60. Mr. van den Bergh previously served as president of Neuroscience Products for Eli Lilly & Company.
Revalesio Corporation hired Bert van den Bergh as president to accelerate commercialization of its therapeutic, RNS60. Mr. van den Bergh previously served as president of Neuroscience Products for Eli Lilly & Company.